Jazz Pharmaceuticals plc (JAZZ)

NASDAQ: JAZZ · Real-Time Price · USD

250.68

+6.14 (2.51%)

At close: Aug 31, 2026, 4:00 PM EDT

250.68

0.00 (0.00%)

Pre-market: Sep 1, 2026, 8:16 AM EDT

Jazz Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	16,273	10,330	7,445	7,744	10,031	7,831
Market Cap Growth	109.99%	38.75%	-3.86%	-22.80%	28.09%	-14.84%
Enterprise Value	18,482	13,713	11,032	11,945	14,946	13,570
Last Close Price	250.68	170.00	123.15	123.00	159.31	127.40

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	17.13	-	13.29	18.67	-	-
Forward PE	9.93	7.67	5.72	6.29	8.54	8.23
PS Ratio	3.54	2.42	1.83	2.02	2.74	2.53
PB Ratio	3.38	2.39	1.82	2.07	3.25	1.98
P/FCF Ratio	10.23	7.96	5.48	7.25	8.07	10.43
P/OCF Ratio	9.80	7.62	5.33	7.09	7.89	10.06
PEG Ratio	0.18	0.55	0.37	0.50	1.14	0.62

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	4.02	3.21	2.71	3.12	4.08	4.39
EV/EBITDA Ratio	9.59	8.00	7.24	8.21	10.18	13.20
EV/EBIT Ratio	15.29	13.47	12.77	14.63	17.81	28.55
EV/FCF Ratio	11.61	10.57	8.13	11.18	12.03	18.07

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.92	1.26	1.51	1.55	1.89	1.56
Debt / EBITDA Ratio	2.25	3.11	3.97	3.92	3.90	5.84
Debt / FCF Ratio	2.77	4.18	4.54	5.43	4.68	8.22
Net Debt / Equity Ratio	0.46	0.69	0.78	1.12	1.60	1.41
Net Debt / EBITDA Ratio	1.15	1.74	2.08	2.87	3.36	5.43
Net Debt / FCF Ratio	1.39	2.30	2.34	3.90	3.97	7.44
Asset Turnover	0.42	0.36	0.35	0.35	0.32	0.33
Inventory Turnover	0.84	0.79	0.58	0.43	0.30	0.37
Quick Ratio	1.38	1.46	3.57	1.52	1.64	1.43
Current Ratio	1.78	1.86	4.46	2.24	2.79	3.23
Return on Equity (ROE)	22.11%	-8.47%	14.31%	12.16%	-6.35%	-8.65%
Return on Assets (ROA)	6.86%	5.38%	4.61%	4.59%	4.53%	3.15%
Return on Invested Capital (ROIC)	17.17%	13.97%	11.39%	10.25%	9.55%	7.13%
Return on Capital Employed (ROCE)	13.70%	10.80%	7.90%	8.30%	8.50%	4.10%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	5.78%	-3.45%	7.52%	5.36%	-2.23%	-4.21%
FCF Yield	9.78%	12.56%	18.24%	13.79%	12.39%	9.59%
Buyback Yield / Dilution	-5.40%	7.61%	8.41%	-15.23%	-4.77%	-5.62%

SEC Filings: 10-K · 10-Q